Navigation Links
Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
Date:3/4/2008

RICHMOND, Va., March 4 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq CM: INSM), a developer of follow-on biologics and biopharmaceuticals, today reported results for the quarter and full-year ended December 31, 2007.

Full-Year 2007 and Recent Company Highlights

-- Follow-on Biologics Program

-- Completed development of INS-19 (Granulocyte Colony Stimulating

Factor or G-CSF) and INS-20 (Peg G-CSF), positioning these

products to enter clinical trials in 2008;

-- Testified at two congressional hearings - "Safe and Affordable

Biotech Drugs - The Need for a Generic Pathway" and "Assessing the

Impact of a Safe and Equitable Biosimilar Policy in the United

States" where Geoffrey Allan, Ph.D., the Company's President and

CEO, urged the need to create a regulatory pathway for the

approval of follow-on biologics ("FOBs") in the U.S.;

-- Appointed Steve Glover, who has approximately 25 years of

biotechnology experience, as President of the Company's FOB

program in order to most effectively leverage Insmed's scientific

capabilities in the field;

-- Completed external market assessment using a major U.S. market

research firm, which indicated a $9 billion annual market

potential for the Company's FOB candidates whose corresponding

innovator products' patents expire within the next eight years;

-- Launched a broad education campaign on the importance of

establishing a regulatory pathway for FOBs in the U.S.; and

-- Commissioned econometric study by economist Dr. Robert J. Shapiro,

former Under Secretary of Commerce in the Clinton Administration,

that identified potential cost savings of approximately $378

billion over the next 20 years from making FOBs a
'/>"/>

SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
2. Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
3. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
4. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
5. Insmed to Appeal Delisting Notification From Nasdaq
6. Insmed Awarded $2.1 Million by Muscular Dystrophy Association
7. Insmed Appoints Dennis M. Lanfear to Board Of Directors
8. Barr Announces Favorable Ruling in Yasmin(R) Patent Challenge
9. Vermillion Announces Effectiveness of Reverse Stock Split
10. Rosetta Genomics Announces Allowance of Two Additional microRNA Patents
11. ROBODOC(R) Announces Patent Cross Licensing Agreement With IBM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014  Decision Resources Group finds ... directors in the United States ... market penetration will be the level of savings ... the expected lower cost to patients. Payers plan ... meet their pricing expectations in order to encourage ...
(Date:7/30/2014)... 2014  Replikins Ltd. today released new data on ... Before the current outbreaks, the mean Ebola Reston gene ... between 1995 and 2002 was 1.1; the mean Replikin ... sixteen-fold in 2013, thus predicting the current outbreaks in ... been shown to be able to predict outbreaks (1). ...
(Date:7/30/2014)... Sales Horizons, a leader in sales ... training programs for companies engaged in complex B2B sales. ... thousands of salespeople over 25 years in market-leading Fortune ... be customized to address the unique sales challenges of ... training program consists of two parts: Mastering the ...
(Date:7/30/2014)... 30, 2014 July 30, 2014. ... biotechnology firm that provides DNA-based authentication and security solutions ... Vice President of Life Sciences, a newly created position, ... Dr. Hogan will lead APDN’s drive to build its ... biotech and healthcare customers, provide guidance to APDN’s R&D ...
Breaking Biology Technology:Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 3Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 2Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 3Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 2Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 3
... 26 Medivation, Inc. (Nasdaq: MDVN) today announced ... Time tomorrow, Tuesday, October 27, to discuss partnering plans for ... testing for the treatment of prostate cancer. , ... call on Tuesday, October 27, at 8:30 a.m. Eastern Time ...
... Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), ... accelerating the development and enhancing the value of oncology ... Research & Development, a Division of Janssen Pharmaceutica NV, ... in Champions, Biomerk Tumorgraft(TM) platform. , "We ...
... ... presented this week at the annual meeting of the Society for Neuroscience ... a stroke. In prior conferences, data from the University of Wisconsin-Milwaukee ... Quincy Bioscience Quincy Bioscience is a partner in the research ...
Cached Biology Technology:Champions Biotechnology Expands Collaboration to Test Oncology Therapeutic in Biomerk Tumorgrafts(TM) 2Champions Biotechnology Expands Collaboration to Test Oncology Therapeutic in Biomerk Tumorgrafts(TM) 3Jellyfish Protein Extends Neuroprotective Tentacles at Neuroscience Conference 2Jellyfish Protein Extends Neuroprotective Tentacles at Neuroscience Conference 3
(Date:7/29/2014)... As the climate warms and sea ice retreats, the ... season of increasingly open water which is predicted to ... of this century. Storms thus have the potential to ... a new and unpredictable element to the region. , A ... waves in the middle of the Arctic Ocean, and ...
(Date:7/29/2014)... a restaurant, don,t blame yourself; blame the menu. What ... want and more to do with a menu,s layout and ... over 300 diners, the Cornell study published this month in ... when it comes to what you order for dinner, two ... how you imagine it will taste. , First, any food ...
(Date:7/29/2014)... Scale plays a major role in locomotion. Swimming microorganisms, ... small inertial forces compared to the viscous forces exerted ... self-propulsion a major challenge. Now, scientists have found that ... is opposite to that induced by a viscoelastic fluid. ... by Franois Nadal from the Alternative Energies and ...
Breaking Biology News(10 mins):Huge waves measured for first time in Arctic Ocean 2Huge waves measured for first time in Arctic Ocean 3Menu secrets that can make you slim by design 2Optimum inertial self-propulsion design for snowman-like nanorobot 2
... Scripps Health announced today it has launched an innovative ... help determine the causes of idiopathic human diseases -- those ... or are unresponsive to standard treatments. The use of ... and treating rare medical cases. Whole genome sequencing provides ...
... identified and mapped the chemical structure of molecules used by ... growth of reef-building coral. Chemicals found on the surfaces ... coral, suggesting that competition with these macroalgae could be a ... of coral reefs. Seaweed growth on coral reefs ...
... difficult to measure accurately each nation,s contribution of carbon dioxide ... ground as coal, gas, and oil, and these fuels are ... generate the energy that is used to make products. In ... where they are consumed. A team led by Carnegie,s Steven ...
Cached Biology News:Scripps launches whole genome sequencing study to find root causes of idiopathic diseases 2Scripps launches whole genome sequencing study to find root causes of idiopathic diseases 3Study identifies molecules used by certain species of seaweed to harm corals 2Study identifies molecules used by certain species of seaweed to harm corals 3Study identifies molecules used by certain species of seaweed to harm corals 4Links in the chain: Global carbon emissions and consumption 2
... Science FLA-5100 imaging system allows imaging of ... 40 x 46cm at a pixel size ... is especially suitable for protein electrophoresis in ... for genomics., Fuji s FLA-5100 includes four ...
... Biometras T1 Thermocycler provides high speed ... been optimized with a TGradient Thermocycler can ... thermocycler comes with a silver block for ... for 384 well plates or in-situ applications ...
... inL10 Workstation from Caliper represents a revolutionary ... the first time the ability to generate ... to changing conditions. In addition, each ... due to changes in temperature, and offers ...
... Vivaclear centrifugal filters are disposable microfiltration devices ... samples in the range 100 l to 500 ... rotors accepting 2.2 ml centrifuge tubes. Product Features: ... pore size Low hold up volume ...
Biology Products: